September 16th, 2026Why Using AI to Interpret Mammogram Results Can Cause Unnecessary PanicPatients often use AI to read test results, but AI can misinterpret data and cause panic. Learn why human context remains critical.Read more
September 16th, 2026Oncology Experts Discuss On-Body Subcutaneous Isatuximab in Multiple MyelomaBeth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinical trials and nursing impacts of on-body isatuximab delivery in multiple myeloma.Read more
September 15th, 2026KEYNOTE-564 5-Year Data: Adjuvant Pembrolizumab Benefits ccRCC KEYNOTE-564 data show adjuvant pembrolizumab maintains DFS and OS benefits in ccRCC. Review key nursing takeaways and safety outcomes.Read more
September 15th, 2026Updated ASTRO Pancreatic Guidelines: Key Takeaways for Oncology NursesASTRO updated its pancreatic cancer radiation guideline. Dr Michael Chuong shares direct takeaways on nursing roles in multidisciplinary care.Read more
September 14th, 2026NCCN Survey: US Cancer Centers Face Generic Oncology Drug ShortagesNCCN survey data show 100% of cancer centers face drug shortages, with ifosfamide and carboplatin critical. Read more
September 14th, 2026Solavia Decision Suite: Key Clinical Insights for APPs and PAsCo-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.Read more
September 12th, 2026FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC PatientsThe FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea. Read more
September 11th, 2026FDA Grants Final Approval to Cabozantinib Capsules Across Multiple Solid Tumor IndicationsFDA approves cabozantinib capsules for RCC, HCC, and epNET. Review key dosing conversions and safety guidelines for oncology nursing practice.Read more